We aimed, for the first time, to investigate the speed and maximum response of TRPM3-dependent Ca2+ influx in ME/CFS patients compared with HC using an immunofluorescent technique. The gene discussed is TRPM3; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.